The Fort Worth Press - Aspire Biopharma Holdings, Inc. to Launch its BUZZ BOMB Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World

USD -
AED 3.672501
AFN 65.000146
ALL 81.796087
AMD 360.510267
ANG 1.789785
AOA 918.000074
ARS 1544.623977
AUD 1.468246
AWG 1.8
AZN 1.703419
BAM 1.763754
BBD 2.014781
BDT 124.426207
BGN 1.747831
BHD 0.377416
BIF 3024.561372
BMD 1
BND 1.28556
BOB 11.709376
BRL 5.615702
BSD 1.000311
BTN 94.028525
BWP 13.87828
BYN 3.01383
BYR 19600
BZD 2.011895
CAD 1.42619
CDF 2315.000159
CHF 0.833902
CLF 0.025158
CLP 990.36943
CNY 6.67035
CNH 6.67075
COP 3307.41
CRC 451.637049
CUC 1
CUP 24.008658
CVE 99.439517
CZK 22.02455
DJF 178.137907
DKK 6.75187
DOP 60.693238
DZD 136.856982
EGP 53.437135
ERN 15
ETB 163.33885
EUR 0.90318
FJD 2.269699
FKP 0.753031
GBP 0.755015
GEL 2.615223
GGP 0.753031
GHS 11.713885
GIP 0.753031
GMD 73.999599
GNF 8862.956934
GTQ 7.643921
GYD 209.287015
HKD 7.844725
HNL 26.899577
HRK 6.76901
HTG 131.072142
HUF 329.957979
IDR 18249
ILS 3.200198
IMP 0.753031
INR 94.03105
IQD 1516.519292
IRR 1906074.999701
ISK 123.295602
JEP 0.753031
JMD 158.465486
JOD 0.709038
JPY 159.850498
KES 129.940245
KGS 87.448901
KHR 4122.27027
KMF 442.000354
KPW 899.999961
KRW 1334.73501
KWD 0.30968
KYD 0.833653
KZT 444.305162
LAK 22511.50962
LBP 89581.865979
LKR 332.667481
LRD 170.058303
LSL 16.673626
LTL 2.95274
LVL 0.60489
LYD 6.450624
MAD 9.853409
MDL 18.24675
MGA 4565.971205
MKD 55.56709
MMK 2099.724407
MNT 3604.903758
MOP 8.08194
MRU 40.45723
MUR 47.360045
MVR 15.416915
MWK 1734.672252
MXN 18.62908
MYR 4.079202
MZN 63.899565
NAD 16.673626
NGN 1346.570013
NIO 36.812748
NOK 9.566995
NPR 150.445279
NZD 1.801955
OMR 0.384482
PAB 1.000401
PEN 3.410816
PGK 4.563225
PHP 63.795955
PKR 276.623544
PLN 3.978735
PYG 6201.019074
QAR 3.646661
RON 4.829396
RSD 106.218992
RUB 82.94774
RWF 1477.740552
SAR 3.774844
SBD 8.090747
SCR 13.853673
SDG 601.502932
SEK 9.998565
SGD 1.286545
SHP 0.749316
SLE 22.903834
SLL 20969.504398
SOS 571.670778
SRD 37.503968
STD 20697.981008
STN 22.094864
SVC 8.752937
SYP 13001.999685
SZL 16.662233
THB 33.861026
TJS 9.228216
TMT 3.5
TND 3.011043
TOP 2.40776
TRY 50.257865
TTD 6.795298
TWD 32.994306
TZS 2659.573959
UAH 45.456661
UGX 4116.859283
UYU 40.546512
UZS 11974.568246
VES 900.490501
VND 25679.5
VUV 119.943861
WST 2.787799
XAF 592.446922
XAG 0.020065
XAU 0.000258795488
XCD 2.70255
XCG 1.802851
XDR 0.707052
XOF 592.446922
XPF 107.551415
YER 236.499474
ZAR 16.743705
ZMK 9001.204186
ZMW 20.431887
ZWL 321.999592
SSP 5786.523514
MXV 2.092613
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

Aspire Biopharma Holdings, Inc. to Launch its BUZZ BOMB Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World
Aspire Biopharma Holdings, Inc. to Launch its BUZZ BOMB Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World

Aspire Biopharma Holdings, Inc. to Launch its BUZZ BOMB Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World

Sublingual nano technology delivers 50mg of caffeine rapidly to the body, bringing its unique benefits to the pre-workout market

Text size:

ESTERO, FL / ACCESS Newswire / July 22, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending supplement delivery technology, today announced it plans to launch its newsublingual pre-workout supplement, BUZZ BOMB™, at FitCon and FitExpo, two of the largest fitness conventions held annually in Salt Lake City, Utah (August 1-2) and Anaheim, CA, (August 2-3), respectively.

Featuring 50mg of caffeine and designed to support sustained energy and mental focus, BUZZ BOMB™ is bringing its unique delivery technology benefits to the multi-billion-dollar pre-workout market to help athletes and fitness enthusiasts maximize their performance potential. Buzz BOMB™, offered in four flavors, provides nearly instant energy, in easy-to-use small sublingual packets, which can be taken right before and during work out as needed. Unlike pre-workout products that are mixed with water and taken well before a workout, BUZZ BOMB™ is sprinkled under the tongue for immediate effect.

FitCon: Mountain America ExpoCenter, Salt Lake City, UT on August 1-2, 2025, Located in Sponsor Alley

FitCon is an event that brings together fitness enthusiasts, professionals, brands, and influencers in the health and wellness industry with approximately 20,000 attendees and hundreds of exhibitors. BUZZ BOMB™ is one of seven "Gold Sponsors" at FitCon, which provides benefits including samples provided to every attendee, a large booth located along "Sponsor Alley" where all attendees pass through, as well as FitCon website marketing, advertising and communications to attendees, and a liberal exhibiting of Buzz Bomb's distinctive trademark throughout the exhibition.

To learn more about FitCon, please visit https://fitcon.com/

The FitExpo: Anaheim Convention Center, Anaheim, CA, August 2-3, 2025, Booth #401

FitExpo brings together a diverse range of fitness brands, competitions, and demonstrations to inspire and guide individuals on their fitness journey and is one of the largest fitness conventions in the world with over 33,000 people expected to attend. As a convention sponsor, BUZZ BOMB™ will be provided numerous benefits and support, including:

  • Booth # 401 is the first one nearest the entry doors to the convention

  • FitExpo will publish a pre-convention media blast about BUZZ BOMB™ to over 1.8 million social media accounts including all attendees

  • BUZZ BOMB™ will be mentioned on all signage throughout the convention, including in the lobby where patrons enter, as well as on the convention's website, newsletter, and social media postings

  • BUZZ BOMB™ products will be in the gift bag given to every entrant (a sample pack of 4 different flavors)

  • BUZZ BOMB is planned to be personally introduced to each influencer at the show

Learn more about FitExpo at https://thefitexpo.com/cities/anaheim/

Company representatives (mostly professional trainers) will be running "Feel the Buzz" contests at both conventions with 250 BUZZ BOMB™ t-shirts offered as prizes to contestants. The Company also plans to sell product at the conventions and generate "BUZZ".

"The launch of BUZZ BOMB™ at two of the major fitness conventions represent the ideal venues to introduce our disruptive pre-workout formula designed to boost endurance, energy metabolism, and overall performance, ensuring that athletes and fitness enthusiasts can perform at their best, both in and out of the gym," said Michael Howe, Chief Executive Officer of Aspire. "We are also very excited about the positive initial consumer feedback we received recently from our sampling of BUZZ BOMB™ to not only fitness trainers and gym owners, but to active and fitness-minded consumers, expanding the addressable market opportunity within the multi-billion-dollar health and wellness categories."

BUZZ BOMB™ Pre-workout Benefits:

• Speed - works nearly immediate vs. 20-30 minutes

• Convenience - easy to use single-use packets vs. mixing and measuring for beverages

• Energy management - use as needed to precisely manage caffeine intake

• Single Safe Active Ingredient - well-known benefits and use of caffeine

• Low manufacturing & packaging costs - competitive pricing with high margin potential

About the Aspire Targeted Oral Delivery Platform

Aspire's technology delivers fast-acting supplement formulations which have been developed by using our patent-pending methodology, and "trade secret" process. The technology's new mechanism of action allows for rapid sublingual absorption. The benefits of "rapid absorption" are to provide rapid impact in more precise quantities.

About Aspire Biopharma, Inc. 

Headquartered in Estero, Fl., Aspire Biopharma has developed a disruptive technology that can deliver supplements and drugs rapidly and precisely. For more information, please visit www.aspirebiolabs.com.

Safe Harbor Statement

Certain statements made in this communication are "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of words such as "estimate," "projects," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "would," "should," "future," "propose," "potential," "target," "goal," "objective," "outlook" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the financial position, business strategy and the plans and objectives of management for future operations. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Aspire's management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of the parties, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Aspire Biopharma Holdings, Inc.

Contact

PCG Advisory
Kevin McGrath
+1-646-418-7002
[email protected]

SOURCE: Aspire Biopharma Holdings, Inc.



View the original press release on ACCESS Newswire

J.P.Cortez--TFWP